Message from Executive Chairman
In the capacity of the Honorary Commandant of the Hong Kong Auxiliary Police Force, I am very proud to have commanded one of the world's finest supporting disciplinary forces, in assisting the Hong Kong Police Force to maintain the law and order, making Hong Kong one of the safest cities in the world.
While retiring from the Auxiliary Police Force which I have served for over 40 years, I was invited to take up the Executive Chairmanship of the Hong Kong Diabetes Health Association, giving me the opportunity to continue serving people! The Auxiliary Police Force is a voluntary force that serves the public and strives for social harmony, making every family filled of positive energy! Relatively, the Hong Kong Diabetes Health Association is a charity organization, all staff are also volunteers, dedicated to help diabetic patients to maintain a healthy condition, simultaneously soothing the pressure of the patient’s family, lives a happy life! Therefore, the Auxiliary Police Force and the Hong Kong Diabetes Association are achieving the same goal with similarities!
In the past 4 years, I have personally witnessed several hundred cases, by having used the “Natural Herbal Tea”, cultivating a healthy lifestyle, proper eating habits and maintaining moderate exercise, their HbA1c levels can significantly be improved within 20 days in the most successful cases. This discovery is indeed a breakthrough in Chinese medicine and may be in the records of western medicine!
In recent years, the development of Chinese medicine has been listed as a national strategy of China. In line with the state's high regard for Chinese medicine, the Association believes that it is the appropriate time to conduct clinical trial study to determine the efficacy of “Natural Herbal Tea” on “HbA1c”
To support the "Healthy Silk Road", the “Global Common Building and Sharing”, and the "Chinese Medicine "One Belt One Road" Development Plan (2016-2020), the Association specially invited experts from various countries, such as China, Malaysia, Singapore, South Korea, Australia, Burma and Hong Kong etc., jointly monitoring this clinical trial study, and plans to promote the result of this study to the "Belt and Road" countries for the benefits of the world.
Lastly, I would like to wish the clinical trial study a complete success!